C-Control: efficacy and safety of therapy with rosuvastatin in statin-naive and in statin-switched patients
Study identifier:NIS-CCH-CRE-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
C-Control: efficacy and safety of therapy with rosuvastatin in statin-naive and in statin-switched patients
Medical condition
Hypercholesteremia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
3392
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Feb 2007
Primary Completion Date: -
Study Completion Date: 01 Jan 2008
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Pt with hypercholesteremia Patients treated with CRESTOR because of hypercholesteremia | - |
